Cannara Biotech Inc. (LOVFF)
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Cannara Biotech Inc.
OTC:LOVFFHealthcare · Drug Manufacturers - Specialty & Generic
+0.42%$1.44
CLOSED · Nov 16Prev close$1.43+0.42%Close$1.44
Mkt Cap$140.52M
EV$159.57M
Float47.39M
O/S97.85M
VOL108 sh
$ Vol$155
RVOL0.01×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.19
EarningsNov 23 · in 6d
Dilution
MCap$140.52MFloat47.39MO/S97.85M
Dilution
Financials Summary
Revenue$75.12M
Net Income$9.15M
Total Assets$118.05M
Free Cash Flow$9.56M
Debt & Equity
Debt 29%
Equity 71%
Total Debt$29.11M
Total Equity$71.56M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:10Reverse splitFeb 13, 202310 shares → 1
Balance Sheet Details
Assets$118.05M
Liabilities$46.5M
Accounts Receivable$9.87M
Accounts Payable$7.76M
Inventory$31.16M
PP&E (Net)$60.2M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 |
| Revenue | $75.12M | $57.22M | $40.08M | $25.09M | $11.91M | $1.79M | $1.47M | $303K |
| YoY Growth | 31.3% | 42.8% | 59.8% | 110.6% | 567.2% | 21.6% | 384.7% | - |
| Cost of Revenue | $42.07M | $36.37M | $21.02M | $12.98M | $4.71M | $929K | $283K | $192K |
| Gross Profit | $33.05M | $20.85M | $19.06M | $12.11M | $7.21M | $857K | $1.19M | $111K |
| Gross Margin | 44.0% | 36.4% | 47.6% | 48.3% | 60.5% | 48.0% | 80.7% | 36.8% |
| Research and Development | $498K | $785K | $722K | $880K | $1.33M | $1.82M | $0 | $0 |
| Selling, General, and Administrative | $16.22M | $13.75M | $9.46M | $7.02M | $5.11M | $6.28M | $7.95M | $1.31M |
| Other | $799K | -$742K | $554K | $751K | $17K | $18K | $0 | $0 |
| Total Operating Expenses | $17.52M | $13.8M | $10.74M | $8.65M | $7M | $9.21M | $8.34M | $1.38M |
| Operating Income (EBIT) | $15.54M | $7.05M | $8.32M | $3.46M | $180K | -$8.37M | -$7.16M | -$1.27M |
| Operating Margin | 20.7% | 12.3% | 20.8% | 13.8% | 1.5% | -468.6% | -487.5% | -420.0% |
| Interest Expense | $2.64M | $2.94M | $3.17M | $2.32M | $1.1M | $928K | $1.06M | $224K |
| Interest Income | $197K | $93K | $168K | $65K | $37K | $186K | $476K | $19K |
| Other Income (Expense) | -$2.87M | -$3.92M | -$3.46M | -$1.84M | -$1.25M | -$799K | -$1.92M | -$207K |
| Income Before Tax (EBT) | $12.67M | $3.14M | $4.86M | $1.61M | -$1.07M | -$9.17M | -$9.08M | -$1.48M |
| Income Tax Expense | $3.51M | -$1.37M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $9.15M | $4.51M | $4.86M | $1.61M | -$1.07M | -$8.74M | -$8.62M | -$1.48M |
| Net Income Margin | 12.2% | 7.9% | 12.1% | 6.4% | -9.0% | -489.4% | -587.3% | -488.4% |
| Supplementary Data | ||||||||
| EPS | 0.14 | 0.07 | 0.08 | 0.03 | -0.02 | -0.17 | -0.17 | -0.03 |
| Diluted EPS | 0.14 | 0.07 | 0.08 | 0.03 | -0.02 | -0.17 | -0.17 | -0.03 |
| Weighted Average OS | 92.37M | 91.52M | 89.30M | 87.67M | 76.52M | 71.33M | 70.68M | 69.38M |
| EBITDA | $19.92M | $10.62M | $11.04M | $5.88M | $2.15M | -$6.43M | -$7.63M | -$1.18M |
| EBITDA Margin | 26.5% | 18.6% | 27.5% | 23.4% | 18.0% | -360.1% | -519.5% | -389.1% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $10.05M | $4.63M | $2.99M | $8.48M | $5.71M | $5.44M | $18.55M | $9.03M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $10.05M | $4.63M | $2.99M | $8.48M | $5.71M | $5.44M | $18.55M | $9.03M |
| Accounts Receivable | $9.87M | $9.13M | $7.42M | $6.03M | $2.08M | $40K | $102K | $154K |
| Inventory | $31.16M | $28.05M | $23.64M | $13.29M | $5.19M | $1.57M | $131K | -$256K |
| Other Current Assets | $4.77M | $5.42M | $2.14M | $0 | $0 | $176K | $625K | $0 |
| Total Current Assets | $57.51M | $47.23M | $36.19M | $28.69M | $13.47M | $7.37M | $19.48M | $9.44M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $60.2M | $59.53M | $62.61M | $59.03M | $50.62M | $30.61M | $27.48M | $9.68M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $114K | $197K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $51K | $51K | $0 | $0 |
| Deferred Tax Assets | $0 | $1.37M | $0 | $0 | $0 | -$51K | $0 | $0 |
| Other Long-Term Assets | $341K | $179K | $273K | $207K | $277K | $297K | $514K | $1.09M |
| Total Long-Term Assets | $60.54M | $61.07M | $62.88M | $59.24M | $50.94M | $31.02M | $28.19M | $10.76M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $118.05M | $108.31M | $99.07M | $87.93M | $64.42M | $38.4M | $47.67M | $20.2M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $7.76M | $6.89M | $6.22M | $6.2M | $4.33M | $1.93M | $3.24M | $764K |
| Short-Term Debt | $9.11M | $6.46M | $4.18M | $1.38M | $212K | $211K | $0 | $0 |
| Current Income Tax Payable | $0 | $5.26M | $736K | $224K | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $93K | $94K | $113K | $32K | $29K | $35K | $0 | -$51K |
| Other Current Liabilities | $0 | $0 | $0 | $542K | $50K | $112K | $230K | $0 |
| Total Current Liabilities | $23.94M | $18.9M | $14.83M | $8.3M | $4.78M | $2.43M | $3.56M | $815K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $19.72M | $26.92M | $27.75M | $32.33M | $14.11M | $8.39M | $8.77M | $8.76M |
| Long-Term Unearned Revenue | $615K | $661K | $600K | $572K | $494K | $357K | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $2.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $53K | $0 | $0 |
| Total Long-Term Liabilities | $22.56M | $27.84M | $28.42M | $32.91M | $14.75M | $9.11M | $9.16M | $9.07M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $46.5M | $46.74M | $43.25M | $41.22M | $19.54M | $11.54M | $12.72M | $9.88M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.27M |
| Common Stock | $62.84M | $61.97M | $62.16M | $58.31M | $58.25M | $40.85M | $38.45M | $11.1M |
| Retained Earnings | $125K | -$9.03M | -$13.54M | -$18.41M | -$20.02M | -$18.95M | -$10.1M | -$1.48M |
| Comprehensive Income & Other | $0 | $0 | -$49K | $11K | $70K | $32K | -$7K | -$1.27M |
| Other Stockholders' Equity | $8.59M | $8.63M | $7.2M | $6.82M | $6.66M | $4.96M | $4.67M | $701K |
| Total Equity | $71.56M | $61.57M | $55.82M | $46.72M | $44.88M | $26.86M | $33.02M | $10.32M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $1.93M | $0 |
| Total Liabilities and Equity | $118.05M | $108.31M | $99.07M | $87.93M | $64.42M | $38.4M | $45.74M | $20.2M |
| Supplementary Data | ||||||||
| Total Debt | $29.11M | $33.83M | $32.05M | $33.87M | $14.63M | $9.05M | $9.26M | $9.12M |
| Net Debt | $19.05M | $29.19M | $29.06M | $25.39M | $8.92M | $3.61M | -$9.3M | $89K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 |
| Operating Activities | ||||||||
| Net Income | $9.15M | $4.51M | $4.86M | $1.61M | -$1.07M | -$9.17M | -$9.08M | -$1.48M |
| Depreciation & Amortization | $4.68M | $4.45M | $3.46M | $2.74M | $2.12M | $1.81M | $396K | $77K |
| Deferred Income Tax | $3.51M | -$1.37M | $0 | $0 | $46K | $34K | $0 | $0 |
| Stock-Based Compensation | $835K | $1.38M | $1.37M | $245K | $232K | $547K | $1.53M | $195K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$156K | -$1.44M | -$1.43M | -$3.97M | -$1.97M | $20K | $52K | -$256K |
| Inventory | -$5.93M | -$2.78M | -$5.83M | -$5.76M | -$2.34M | -$1.15M | -$131K | $0 |
| Accounts Payable | $370K | $1.55M | $0 | $0 | $1.53M | $651K | $367K | $764K |
| Other Working Capital | $1.3M | $922K | -$629K | $16K | $115K | $275K | -$110K | $530K |
| Total Working Capital Change | -$4.41M | -$1.75M | -$7.89M | -$9.71M | -$2.67M | -$203K | $179K | $274K |
| Other Non-Cash Items | $240K | $257K | $2.34M | $857K | -$118K | $452K | $1.79M | $224K |
| Net Cash from Operating | $14.01M | $7.48M | $4.14M | -$4.26M | -$1.47M | -$6.53M | -$5.19M | -$807K |
| Investing Activities | ||||||||
| Capital Expenditures | -$4.45M | -$5.23M | -$6.92M | -$10.83M | -$21.75M | -$6.17M | -$15.62M | -$10.49M |
| Acquisitions | $0 | $0 | $0 | $0 | $152K | $352K | $682K | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $286K | $1.6M | $281K | $85K | $19K | -$168K | -$207K | -$1.45M |
| Net Cash from Investing | -$4.17M | -$3.63M | -$6.63M | -$10.74M | -$21.58M | -$5.99M | -$15.15M | -$10.49M |
| Financing Activities | ||||||||
| Debt Repaid | $2.16M | $1.56M | $1.57M | -$19.31M | -$7.06M | $394K | $165K | -$8.79M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $17.01M | $488K | $32.36M | $12.37M |
| Common Stock Repurchases | $0 | -$194K | -$262K | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$2.62M | -$2.73M | -$1.1M | -$1.48M | -$792K | -$247K | -$2.33M | -$820K |
| Net Cash from Financing | -$4.43M | -$2.2M | -$2.94M | $17.83M | $23.28M | -$640K | $29.86M | $20.33M |
| Forex Effect | $0 | $0 | -$59K | -$59K | $41K | $39K | -$12K | $0 |
| Net Change in Cash | $5.42M | $1.64M | -$5.49M | $2.77M | $272K | -$13.11M | $9.52M | $9.03M |
| Supplementary Data | ||||||||
| Operating Cash Flow | $14.01M | $7.48M | $4.14M | -$4.26M | -$1.47M | -$6.53M | -$5.19M | -$807K |
| Capital Expenditure | -$4.45M | -$5.23M | -$6.92M | -$10.83M | -$21.75M | -$6.17M | -$15.62M | -$10.49M |
| Free Cash Flow | $9.56M | $2.25M | -$2.78M | -$15.08M | -$23.22M | -$12.7M | -$20.81M | -$11.3M |
| Cash at Beginning | $4.63M | $2.99M | $8.48M | $5.71M | $5.44M | $18.55M | $9.03M | $0 |
| Cash at End | $10.05M | $4.63M | $2.99M | $8.48M | $5.71M | $5.44M | $18.55M | $9.03M |